Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

HERZLIYA, Israel and CALGARY, Alberta, April 1, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), ... Lees verder

Bron:

Health